Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 294, 151-157
Abstract
No abstract availableKeywords
Funding Information
- Korea Institute of Oriental Medicine
- Ministry of Education, Science and Technology
This publication has 34 references indexed in Scilit:
- Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinaseChemico-Biological Interactions, 2018
- Nonalcoholic Fatty Liver DiseaseJAMA, 2015
- Interplay of reactive oxygen species, intracellular Ca2+ and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxinJournal of Cellular Biochemistry, 2012
- Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensisFree Radical Biology and Medicine, 2010
- Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injuryFree Radical Biology and Medicine, 2009
- Role of adenosine monophosphate‐activated protein kinase–p70 ribosomal S6 kinase‐1 pathway in repression of liver X receptor‐alpha–dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones†Hepatology, 2009
- AMPK: An Emerging Drug Target for Diabetes and the Metabolic SyndromeCell Metabolism, 2009
- Molecular basis and mechanisms of progression of non-alcoholic steatohepatitisTrends in Molecular Medicine, 2008
- Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)Drug Discovery Today, 2007
- SREBP-1c expression in Schwann cells is affected by diabetes and nutritional statusMolecular and Cellular Neuroscience, 2007